Navigation Links
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
Date:5/13/2008

CRANBURY, N.J., May 13 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN) today reported its financial results for the third quarter ended March 31, 2008 and announced new strategic objectives as part of a restructuring of its clinical-stage product portfolio and development programs. Palatin will continue to develop products targeting melanocortin and natriuretic receptors in the sexual dysfunction, obesity, and cardiovascular fields, including acute hospital care products for use in treatment of acute systemic hypertension, congestive heart failure and hemorrhagic shock. The restructuring focuses the Company's resources on the programs and opportunities that management believes are most likely to increase shareholder value. Additional details will be provided by management in a conference call today at 11:00 a.m. Eastern Time.

Strategic Restructuring

Palatin has undertaken a strategic restructuring with the following elements and objectives:

-- Following a detailed evaluation, including review of regulatory and

commercial information and data on its new melanocortin compounds under

development for sexual dysfunction, Palatin has discontinued

development of bremelanotide for the treatment of male and female

sexual dysfunction;

-- Developing bremelanotide as a therapeutic drug for treatment of

hemorrhagic shock and related indications (shock induced by blood loss,

such as secondary to surgery or trauma);

-- Initiating a Phase 2A study this quarter with PL-3994, Palatin's

natriuretic peptide receptor A agonist compound, in patients with

controlled hypertension;

-- Initiating a Phase 2A study of PL-3994 durin
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
2. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
3. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
4. Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007
5. Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
8. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
9. Veran Medical Technologies Secures $4.75M in First Institutional Funding
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. InSet Technologies Appoints Jon Tremmel to its Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...EIM, Ontario, Nov. 24 Do...ing the assets of Hyland Seeds, a division of Thom...f Hyland Seeds will further expand Dow AgroScience...es the introduction of SmartStax(TM) in 2010 ...hnology in corn in 2012. The transactional close i...
(Date:11/24/2009)...alth care employment grew by 29,000 jobs in Octob...sistent growth during the U.S. recession. However,..., and health systems are coming closer to having t...administrators. , (Vocus)...nued growing in October despite the shedding of jo...
(Date:11/24/2009)...lif., Nov. 24 NeurogesX,...y focused on developing and commercializing novel ...thony DiTonno, President and Chief Executive Offic...er Jaffray Health Care Conference, to be held Dece... York, New York. ,, Mr. DiTonno and Stephen Gh...
(Date:11/24/2009)... FBI recently approved the Promega PowerPlex 16 HS...r generating DNA records for the National DNA Inde...SA (PRWEB) -- The FBI recently approved the Promeg...ories participating in, or generating DNA records ...rrently contains more than seven million profiles ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...essor Bart P. Miller Madison, Wis. The Univers...earch universities to receive a grant from the In...2004 high-power computing conference in Philadelph...team led by Barton Miller , a UW-Madison professo...Miller and his team for their work on scalable per...
...is new book The Art of the Start: The Time-Tested...ng, , Guy Kawasaki, a managing director of Garage ... focusing on obtaining venture capital, most entre...enerating new customer leads and solidifying custo... the delivery is biting and sarcastic. Bill Reiche...
...election is over. Discounting some mutterings on t.... Thats not an assessment of the outcome, but rath...wildly divergent opinions of whats important and w...was some, shall we say, unpleasantness and less th...inly it will take us many years to fully understan...
Other Biology Technology:Scalable performance monitoring software draws grant from Intel 2Sarcasm and rainmaking advice coexist in The Art of the Start 2Sarcasm and rainmaking advice coexist in The Art of the Start 3Sarcasm and rainmaking advice coexist in The Art of the Start 4Sarcasm and rainmaking advice coexist in The Art of the Start 5Technology and democracy 2Technology and democracy 3
(Date:11/23/2009)...nts strong evidence that the "synergistic" effect ...ated pollution and indoor endotoxin causes more ha...ure alone. , Environmental health scientists a...icine have shown that children exposed to both hig...ndotoxin during early life are six times more like...
(Date:11/23/2009)...e Conservation Society says that western lowland g... Congopart of the "mother lode" of more than 125,0...asingly threatened by growing humans activity in t...the swamp forests adjacent to the southwest border...confirmed that high densities of the great apes st...
(Date:11/23/2009)...e vaccine available for the H1N1 virus has been se...us. The vaccination marks the first time vaccine h...ndemic flu., Iowa State University,s Hank Harris...ne this summer and has been shipping preventive do...s for several weeks., The latest vaccines were s...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Rockford 26apos 3Bs CRC Celebrates Two Years with Continued Rapid Growth Recovery of Unpaid Hospital Bills 3B Good Business in a Bad Economy 60025 1Rockford 26apos 3Bs CRC Celebrates Two Years with Continued Rapid Growth Recovery of Unpaid Hospital Bills 3B Good Business in a Bad Economy 60025 2Rockford 26apos 3Bs CRC Celebrates Two Years with Continued Rapid Growth Recovery of Unpaid Hospital Bills 3B Good Business in a Bad Economy 60025 3Pendleton by Jill Rappaport Launches In Store 3B Raises Funds for Animal Health and Wellness and Indian College Fund 60021 1Pendleton by Jill Rappaport Launches In Store 3B Raises Funds for Animal Health and Wellness and Indian College Fund 60021 2ZyDoc Launches MediSapien 26amp 3B 238482 3B Telephone Information Management Service Featuring Appointment Reminder System to Improve Efficiency Red 60017 1ZyDoc Launches MediSapien 26amp 3B 238482 3B Telephone Information Management Service Featuring Appointment Reminder System to Improve Efficiency Red 60017 2ZyDoc Launches MediSapien 26amp 3B 238482 3B Telephone Information Management Service Featuring Appointment Reminder System to Improve Efficiency Red 60017 3
... against infection may do so because the normal de...ed. , Purdue University researchers found that th...to, the molecule that triggers the infection respo...does, however, allow this group of plants, called ...etal in their tissues, rendering them pathogen res...
...besity scale in a new international study of adole...anssen, a professor in Queen,s University,s School... of Community Health & Epidemiology. , And sed...rongly correlated with being overweight, he adds. ...ns contrary to what the research team expected. Su...
...y announced a series of important changes pertaini...ammatory class of drugs, including COX-2 selective...ounter (OTC)) non-selective NSAID medications. A l... at http://www.fda.gov/cder/drug/infopage/cox2/def...he health of the millions of Americans who rely on...
Other Biology News:Defenseless plants arm themselves with metals 2Defenseless plants arm themselves with metals 3Defenseless plants arm themselves with metals 4Canadian youth 4th highest in international obesity study 2FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2
Klenow Enzyme; labeling grade, DNA Polymerase I, large fragment from Roche Applied Science
DNA Polymerase I Large (Klenow) Fragment from New England Biolabs
T4 DNA Ligase (HC) from Invitrogen
Rat Anti-STENOTROPHOMONAS MALTOPHILIA Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: